Copyright
©The Author(s) 2018.
World J Gastroenterol. Dec 14, 2018; 24(46): 5203-5214
Published online Dec 14, 2018. doi: 10.3748/wjg.v24.i46.5203
Published online Dec 14, 2018. doi: 10.3748/wjg.v24.i46.5203
Author | Study period | n | Definedexclusioncriteria for LT | General severityat LT | MELDat LT | Prognostic factorsofpost-transplantmortality | Post-transplant survival |
Umgelter et al[12] | 2007-2009 | 13 | Subjective | SOFA19 | 38 | Increasing MELD during first 48 h and longer ICU stay | 46% at 1 yr |
Karvelllas et al[16] | 2000-2009 | 198 | No | SOFA 14 | 34 | Not SOFA | 62% at 3 yr |
Recipient age > 60 yr | |||||||
Duan et al[27] | 2004-2012 | 100 | No | SOFA 9 | 32 | LDLT = DDLT | 78% at 1 yr |
Finkenstedt et al[9] | 2002-2010 | 33 | Subjective | RRT 30% | 28 | No | 87% at 1 yr |
MV 9% | |||||||
Petrowsky et al[13] | 2002-2010 | 133 | No | RRT 90% | > 40 | MELD | 64% at 3 yr |
Age adjusted-Charslon index | |||||||
MV 66% | Cardiac risk | ||||||
Septic shock | |||||||
Knaak et al[15] | 2000-2013 | 122 | FiO2 > 40% | SOFA 15 | 32 | Glasgow Coma Score < 7 before intubation | 76% at 3 yr |
Norepinephrine > 0.1 µg/kg per min | |||||||
Levesque et al[19] | 2008-2013 | 30 (ACLF3) | No | SOFA 16 | 37 | No | 43% at 1 yr |
Moon et al[45] | 1998-2010 | 190 | No | RRT 43% | 38 | No | 70% at 5 yr |
MV 36% | |||||||
Artru et al[10] | 2008-2014 | 73 (ACLF3) | No active GI bleeding | SOFA 16 | 38 | No | 84% at 1 yr |
Norepinephrine < 3 mg/h | |||||||
PaO2/FiO2 < 150 mmHg | |||||||
Michard et al[44] | 2007-2015 | 55 | No | SOFA 16 | 42 | Lactate > 5 mmol/L | 60% at 1 yr |
ARDS with PaO2/FiO2 < 200 mmHg | |||||||
Thuluvath et al[43] | 2002-2016 | 677 | No | 5 or 6 OF | 40 | Age, intubation | 81% at 1 yr |
- Citation: Artzner T, Michard B, Besch C, Levesque E, Faitot F. Liver transplantation for critically ill cirrhotic patients: Overview and pragmatic proposals. World J Gastroenterol 2018; 24(46): 5203-5214
- URL: https://www.wjgnet.com/1007-9327/full/v24/i46/5203.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i46.5203